Merck & Co., Inc. (MRK)

122.26 +0.40 (+0.33%) USD  |  NYSE  |  Feb 20, 16:00
122.20 -0.06 (-0.05%) Pre-Market: 04:08
More

Merck Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade